GlassScriptPhysician profile
Hugo A Leon
NPI 1114030095
$3,086.58
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,934 · 2020: $152.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $390.84 | 2019-2020 | |
| Amgen INC. | $387.69 | 2019 | |
| Pfizer INC. | $338.46 | 2019 | |
| Allergan, INC. | $282.07 | 2019 | |
| Novo Nordisk INC | $258.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $193.53 | 2019 | |
| Lilly USA, LLC | $159.92 | 2019 | |
| Glaxosmithkline, LLC. | $126.04 | 2019 | |
| Amarin Pharma, INC. | $123.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $121.47 | 2019 | |
| Sanofi Pasteur INC. | $82.02 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.61 | 2019 | |
| Merck Sharp & Dohme LLC | $71.22 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.55 | 2019 | |
| Arbor Pharmaceuticals, INC. | $61.94 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.39 | 2019 | |
| Fidia Pharma USA INC. | $34.42 | 2019 | |
| Astellas Pharma US INC | $29.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.13 | 2019 | |
| Collegium Pharmaceutical, INC. | $26.45 | 2019 | |
| Medtronic USA, INC. | $19.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.78 | 2019 | |
| Mylan Specialty L.P. | $18.00 | 2019 | |
| Hologic Sales and Service, LLC | $17.96 | 2019 | |
| Pacira Therapeutics, INC. | $17.31 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugo Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.